封面
市场调查报告书
商品编码
1608860

去识别化健康资料市场:按资料类型、按应用、按最终用户、按地区

De-identified Health Data Market, By Type of Data, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

去识别化健康资料市场预计到 2024 年将达到 75.1 亿美元,预计到 2031 年将达到 138 亿美元,2024 年至 2031 年复合年增长率为 9.1%。

报告范围 报告详情
基准年 2023年 2024年市场规模 75.1亿美元
实际资料 2019-2023 预测期 2024年至2031年
预测 2024-2031 年复合年增长率: 9.10% 2031 年金额预测 138亿美元
图:2024 年按地区分類的去识别化健康资料市场占有率(%)
去识别化健康数据市场-IMG1

去识别化医疗资料市场的成长是由药物发现和精准医学研发活动的增加所推动的。去身分化透过从健康资料集集中删除姓名、出生日期和社会安全号码等识别码来确保病患的隐私和机密性。这使得研究人员和生命科学公司能够在不损害道德的情况下利用大量健康资料来开发新治疗方法和流行病学研究。随着世界范围内健康记录数位化的加速,可供二次使用的去识别化资料量将会增加。

市场动态

对基于价值的护理、个人化护理以及数位医疗新兴企业的成长的日益关注可能会推动全球对去识别化医疗资料的需求。然而,资料标准化的缺乏和知识产权的模糊性可能会阻碍市场潜力。高阶分析功能的发展为企业提供了从汇集的资料资产中获得更深入见解的机会。扩大政府开放资料共用倡议可以扩大对这些资料集的存取。美国政府推出了Data.gov 和 HealthData.gov 等倡议,提供对各种健康相关资料集集的开放访问,以促进公共卫生研究的透明度和创新。

本研究的主要特点

本报告对全球去识别化健康资料市场进行了详细分析,包括年复合成长率(CAGR%)。发布。

它还揭示了各个细分市场的潜在商机,并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数,介绍了全球去识别化健康资料市场的主要企业。

本研究涵盖的主要企业包括 IQVIA、 Oracle(Cerner Corporation)、Merative (Truven Health Analytics)、Optum, Inc.、BioTelemetry, Inc.、Flatiron Health、Veradigm LLC、Medidata Solutions、Evidation Health, Inc.、Komodo Health , Inc.、Sundown Solutions, LLC、Clarify Health Solutions、Akrivia Health、Satori Cyber​​ Ltd.、Tempus、nference、Ciox Health、HealthVerity、Zebra Medical Vision 和 Huma Therapeutics。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球去识别化健康资料市场报告针对该行业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员可以透过用于分析全球去识别医疗资料市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规及趋势分析

  • 市场动态
  • 促进因素
  • 抑制因素
  • 机会
  • 影响分析
  • 主要进展
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景
  • 产业动态

第 4 章 去识别化健康资料市场,依资料类型划分,2019-2031

  • 临床资料
  • 基因组资料
  • 患者人口统计
  • 处方资料
  • 索赔资料
  • 行为资料
  • 穿戴式装置和感测器资料
  • 调查和患者报告的资料
  • 影像资料
  • 检验资料
  • 健康的社会决定因素 (SDOH)资料
  • 其他的

第五章 去识别化健康资料市场,依应用划分,2019-2031

  • 临床研究和临床实验
  • 公共卫生
  • 精准医疗
  • 卫生经济学和结果研究(HEOR)
  • 人口健康管理
  • 药物发现与开发
  • 提高医疗保健品质
  • 核保和风险评估
  • 其他的

第 6 章 去识别化健康资料市场,依最终使用者划分,2019-2031 年

  • 製药公司
  • 生技公司
  • 医疗服务提供方
  • 保险公司/医疗保健付款人
  • 研究所
  • 政府机构
  • 其他的

第七章 去识别化健康资料市场,依地区划分,2019-2031

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第八章 竞争格局

  • IQVIA
  • Oracle(Cerner Corporation)
  • Merative(Truven Health Analytics)
  • Optum, Inc.
  • BioTelemetry, Inc.
  • Flatiron Health
  • Veradigm LLC
  • Medidata Solutions
  • Evidation Health, Inc.
  • Komodo Health, Inc.
  • Sundown Solutions, LLC
  • Clarify Health Solutions
  • Akrivia Health
  • Satori Cyber Ltd.
  • Tempus
  • nference
  • Ciox Health
  • HealthVerity
  • Zebra Medical Vision
  • Huma Therapeutics

第九章 分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会图

第10章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI7476

De-identified health data market is estimated to be valued at USD 7.51 Bn in 2024 and is expected to reach USD 13.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: 7.51 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 9.10% 2031 Value Projection: 13.80 Bn
Figure. De-identified Health Data Market Share (%), By Region, 2024
De-identified Health Data Market - IMG1

De-identified health data market growth is driven by increasing research and development activities for drug discovery and precision medicine. De-identification ensures patient privacy and confidentiality by removing identifiers such as name, date of birth, social security number, and others from health data sets. This allows researchers and life science companies to utilize large pools of health data for developing novel therapies and epidemiological studies without compromising on ethics. As digitization of health records accelerates across the world, there will be increase in amount of de-identified data available for secondary usage.

Market Dynamics

Rising focus on value-based care, personalization of treatment, and growth of digital health startups can boost demand for de-identified health data globally. However, lack of data standardization and ambiguity over intellectual property rights can hamper the market potential. Development of advanced analytics capabilities offers an opportunity for players to unlock deeper insights from pooled data assets. Growing open data sharing initiatives by governments can widen the access to these data sets. The U.S. government has launched initiatives like Data.gov and HealthData.gov that offers open access to a wide range of health-related datasets to encourage transparency and innovation in public health research.

Key features of the study

This report provides in-depth analysis of the global de-identified health data market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global de-identified health data market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include IQVIA, Oracle (Cerner Corporation), Merative (Truven Health Analytics), Optum, Inc., BioTelemetry, Inc., Flatiron Health, Veradigm LLC, Medidata Solutions, Evidation Health, Inc., Komodo Health, Inc., Sundown Solutions, LLC, Clarify Health Solutions, Akrivia Health, Satori Cyber Ltd., Tempus, nference, Ciox Health, HealthVerity, Zebra Medical Vision, and Huma Therapeutics

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global de-identified health data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global de-identified health data market

Market Segmentation

  • Type of Data Insights (Revenue, USD Bn, 2019 - 2031)
    • Clinical Data
    • Genomic Data
    • Patient Demographics
    • Prescription Data
    • Claims Data
    • Behavioral Data
    • Wearable and Sensor Data
    • Survey and Patient-Reported Data
    • Imaging Data
    • Laboratory Data
    • Social Determinants of Health (SDOH) Data
    • Others
  • Application Insights (Revenue, USD Bn, 2019 - 2031)
    • Clinical Research and Trials
    • Public Health
    • Precision Medicine
    • Health Economics and Outcomes Research (HEOR)
    • Population Health Management
    • Drug Discovery and Development
    • Healthcare Quality Improvement
    • Insurance Underwriting and Risk Assessment
    • Others
  • End User Insights (Revenue, USD Bn, 2019 - 2031)
    • Pharmaceutical Companies
    • Biotechnology Firms
    • Healthcare Providers
    • Insurance Companies/Healthcare Payers
    • Research Institutions
    • Government Agencies
    • Others
  • Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • IQVIA
    • Oracle (Cerner Corporation)
    • Merative (Truven Health Analytics)
    • Optum, Inc.
    • BioTelemetry, Inc.
    • Flatiron Health
    • Veradigm LLC
    • Medidata Solutions
    • Evidation Health, Inc.
    • Komodo Health, Inc.
    • Sundown Solutions, LLC
    • Clarify Health Solutions
    • Akrivia Health
    • Satori Cyber Ltd.
    • Tempus
    • nference
    • Ciox Health
    • HealthVerity
    • Zebra Medical Vision
    • Huma Therapeutics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • De-identified Health Data Market, By Type of Data
    • De-identified Health Data Market, By Application
    • De-identified Health Data Market, By End User
    • De-identified Health Data Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. De-identified Health Data Market, By Type of Data, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Clinical Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Genomic Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Patient Demographics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Prescription Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Claims Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Behavioral Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Wearable and Sensor Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Survey and Patient-Reported Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Imaging Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Laboratory Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Social Determinants of Health (SDOH) Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. De-identified Health Data Market, By Application, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Clinical Research and Trials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Public Health
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Precision Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Health Economics and Outcomes Research (HEOR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Population Health Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Drug Discovery and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Healthcare Quality Improvement
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Insurance Underwriting and Risk Assessment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. De-identified Health Data Market, By End User, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Biotechnology Firms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Healthcare Providers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Insurance Companies/Healthcare Payers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Government Agencies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. De-identified Health Data Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type of Data, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive landscape

  • IQVIA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Oracle (Cerner Corporation)
  • Merative (Truven Health Analytics)
  • Optum, Inc.
  • BioTelemetry, Inc.
  • Flatiron Health
  • Veradigm LLC
  • Medidata Solutions
  • Evidation Health, Inc.
  • Komodo Health, Inc.
  • Sundown Solutions, LLC
  • Clarify Health Solutions
  • Akrivia Health
  • Satori Cyber Ltd.
  • Tempus
  • nference
  • Ciox Health
  • HealthVerity
  • Zebra Medical Vision
  • Huma Therapeutics

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us